What Dermatologists & Surgeons Need To Know: Adjuvant Treatment for Resectable Stage II Melanoma
This educational initiative will enhance dermatologists' and surgeons' knowledge, clinical skills, and confidence in recognizing patients who may benefit from adjuvant systemic therapy and selecting individualized, appropriate agents to improve outcomes for patients with stage IIB-IV resectable melanoma.
Create your
podcast in
minutes
It is Free